Tg Therapeutics shares rise 5.08% intraday after completing a $100 million share repurchase program.

Tg Therapeutics, Inc. rose 5.08% in intraday trading, with the company announcing a new $100 million share repurchase program. This follows the completion of a previous $100 million share repurchase program, which saw the company repurchase approximately 3.5 million shares at an average price of $28.55 per share. The new program allows the company to acquire up to an additional $100 million of its common stock, which is seen as a bullish move by investors.